Changes in the plasma concentration of C-reactive protein were assessed as a diagnostic test for sepsis in critically ill patients. Forty-nine episodes of secondary sepsis were identified in 31 patients. In 43 out of the 49 episodes there was a 25% or greater change in the concentration of C-reactive protein on the day that sepsis was diagnosed but in six episodes of sepsis the change was less than 25%. A 25% rise in the plasma concentration of C-reactive protein in the absence of other non-infective causes of a raised C-reactive protein, such as inflammation, tissue injury or surgery, is highly suggestive of infection, but failure of the C-reactive protein to rise does not eliminate a diagnosis of sepsis.
CRP has been shown to be proportional to the amount of damage following tissue injury,IS but, while large increases occur in response to infection, no conclusive quantitative correlation between infection and the change in C-reactive protein has been demonstrated.
In critically ill patients, many of the factors causing changes in the CRP are likely to be present so that 'normal' values are extremely variable. Nevertheless infection is a potent stimulus for the production of CRP and a rise in the plasma concentration may be seen. The purpose of this study was to determine whether changes in the plasma concentration of CRP could be used to assist the diagnosis of sepsis in the critically ill. METHOD All episodes of secondary sepsis occurring in the intensive care unit were studied. In order to achieve this, each patient admitted to the Intensive Care Unit over a one year period was entered into the study and each patient had, in addition to normal investigations, a daily CRP estimation. Patients remained in the study until the time of discharge from the Intensive Care Unit. The clinical problem at presentation was frequently associated with high CRP values so that, for the purpose of the study, these changes were excluded. Only episodes occurring following stabilisation of the presenting problem were considered suitable for inclusion. The patient had to enter a stable, sepsis-free period, at which time any episode subsequently developing was considered to be secondary infection. Any patient in this category who underwent surgery in close temporal relation to the development of a septic episode was also excluded from the study as surgery is known to influence CRP value significantly.
Rate nephelometry is the standard method of assay for C-reactive protein and it is increasingly available for clinical use from immunological laboratories, especially in hospitals with transplant facilities. In this study measurement was by rate nephelometry on Beckman array (High Wycombe, Bucks, U.K.). The lower limit of detection was 6 mg/I. The test costs in the order of$6 (reagent cost of about $1.00) and this includes allowance for staff costs.
A daily assessment of each patient was made and sepsis evaluated using the following criteria (modified from Jordan et aI. 16 ). Following the discharge from ICU of each patient who had developed episodes of secondary sepsis, the CRP values were retrospectively assessed for each episode. The CRP value on the day before sepsis was diagnosed was taken as a baseline and compared with the value on the day of diagnosis. An increase of 25% was taken as a positive result. As all samples were taken at the same time in the morning, no attempt was made to determine the temporal relationship between the rise in CRP and the changes in other parameters such as white cell count or temperature.
During the period of the study, any other rises in CRP were also evaluated retrospectively and inexplicable rises noted.
RESULTS
A total of 347 patients were included in the study and 1395 CRP tests were performed. During the twelve-month period of the study there were a total of 49 episodes of 'isolated' secondary sepsis which occurred in 31 patients. Of these, 20 were classified as definite, 21 were probable and 8 possible.
CRP changes of 25% or greater occurred in 43 of the 49 episodes of sepsis (88%). It rose in 16 of the definite, 20 of the probable and seven of the possible episodes of sepsis. CRP failed to rise in four of the definite, one of the probable and one of the possible episodes of sepsis, a total of six false negative results (12%).
During the study there were only three occasions where the C-reactive protein rose by more than 25% without an identified cause. On those occasions there was no evidence, either clinical or laboratory, of sepsis nor interventions such as surgery, and these were considered false positive results. These results demonstrate that using a change in CRP of 25% the test has a sensitivity for the diagnosis of sepsis of 87% with a positive predictive value of 93%.
The design of the study precluded evaluation of true negative results and so it was not possible to define specificity but in view of the range of influences which may affect CRP in the intensive care environment, a low specificity would be expected.
The range of CRP values on admission was from 5-248 mg/l with a median value of 70 mg/l (25th and 75th percentiles, 43,105). The range ofbaseline CRP values in the secondary sepsis group was 5-155 mg/l (median 69, 25th and 75th percentiles, 32,91). The range of changes in CRP was from 9-249 mg/I which represented a range of percentage increases of 15-2400.
In the study the white cell count rose (> 25%) in eight, and fell in three of the 20 patients in the definite sepsis group. In the probable sepsis group, (21 patients), it rose in 16 and fell in one. In the possible sepsis group it rose in two patients and fell in one.
The temperature rose by more than 1°C in thirteen of the definite sepsis group, fell by more than 1 °C in two and there was a change ofless than one degree in five patients. In the probable group the temperature rose in fifteen and fell in none. In the possible sepsis group a temperature change occurred in one patient and this was a fall. DISCUSSION In contrast to that in other populations, the value of CRP is rarely within normal values in intensive care patients either on admission or during stable periods in their management. As with other tests such as the white cell count, the trend in the measurements may be of greater clinical value than absolute figures. In this study CRP was measured daily and an increase of 25% was arbitrarily taken as a significantly change. A change of this magnitude or greater was seen to occur in a high proportion of the patients identified as developing sepsis.
It is well recognised that CRP rises in response to bacterial infection and it has been used as a diagnostic marker of sepsis in a wide range of clinical populations. These include neonates,7, 17 patients with immunodeficiency, 18·21 general paediatrics,22 obstetrics and the elderly.23,24 It has also been used in specific clinical circumstances such as the diagnosis of appendicitis, 25 in obstetrics for the diagnosis of preterm infection 8 ,26,27 and in spinal injury patients to indicate urinary tract infection. 28 In all of these circumstances the baseline value for CRP should be the same as for the. normal population, 12 i.e. less th.an 10 mg/l, and a slllgle measurement demonstratlllg an elevated value may well be of significance. There are exceptions to this general statement as there are many other causes of an elevated level. These include inflammatory problems, such as systemic lupus erythematosis and rheumatoid arthritis, as well as tissue injury either through trauma or surgery. Nevertheless in the normal population with none of these problems, the measurement of CRP may be extremely helpful in the diagnosis of sepsis.
In other clinical populations it is more difficult to interpret the CRP as other factors present have significant influence on the plasma concentration. The influence of surgery has been studied. A rise from control values (10-20 mg/l), was seen following surgery and peaked at about 48 hours before falling slowly back towards the normal range. The rise was influenced by the magnitude of the surgery with values in the order of 50 mg/l following a hernia repair and 300 mg/l following major abdominal trauma and surgery.29 Trauma influences CRP in a similar manner to surgery with the value of the CRP noted to be in proportion to the injury. In the study in which this was reported the plasma concentrations fell at about day four except in the group with sepsis in which they rose still further to values in the order of 150-200 mg/l. 30 Patients with abdominal sepsis have been studied 31 and the conclusions drawn were that CRP was elevated with abdominal sepsis and remained elevated if the infection persisted. The surgery itself caused a rise in CRP which fell over four to five days and CRP only rose again if reinfection occurred with values of greater than 100 mg/l indicating sepsis. This value was also suggested as representing a relatively specific indicator of infection in a study evaluating bacteraemia. 32 The information available from these studies suggests that CRP is a reasonably reliable, if nonspecific, indicator of sepsis. Therefore the test should be potentially useful in the intensive care situation where diagnosis of sepsis is a common and difficult problem. However, the methods described in previous studies are inappropriate to the adult intensive care environment for several reasons. Foremost is the observation that the CRP ~s influenc:ed by most forms of tissue injury or lllflammatlOn so that the specificity would be expected to be low. As a consequence it is necessary to examine the population at a time at which there are as few confounding influences as possible. In the critically ill this requires the diagnosis of episodes of sepsis occurring in relative isolation during their management, and as accurate diagnosis is difficult, it is then necessary to use a classification for sepsis. A second problem is that in most of the studies, absolute values of CRP have been used to diagnose infection by comparison with the values of normal population controls. In the critically ill these controls do not exist as can be seen by the ranges of admission and baseline presepsis values in this study, nor do absolute values, such as a plasma concentration of 100 mg/l, specifically indicate sepsis. However even with high plasma concentrations, further indreases occur if sepsis develops and so this aspect of the change in plasma concentration of CRP in response to sepsis can be assessed. A further problem is that in order to place the measurement of changes in CRP as an indicator of sepsis in perspective, it should be compared with other commonly used criteria such as the white cell count and temperature.
Considering the daily use of these two variables to identify sepsis, there is remarkably little information in the literature regarding their· specificity or sensitivity in the critical ill, although both are almost certainly low. In this study white cell count and temperature were used as part of the classification of sepsis and so comparison with CRP was not possible, and this emphasises the difficulties intrinsic in comparative studies within this population. A potentially useful aspect of CRP measurement not addressed in this study is the role of CRP as a means offollowing the resolution of sepsis. Several studies have demonstrated that the CRP falls as infection resolves, but they have also shown both a failure to fall with a lack of response to treatment and a secondary rise in the prescence of reinfection. 4 ,28,31,32 Further study is required in the critically ill population to evaluate the role of the measurement of CRP as a means of following the response to treatment.
The data from this study demonstrates that in the critically ill, a 25% change in the value of C-reactive protein occurred in 85% of isolated secondary septic episodes, but failed to rise in 12%. In critically ill patients, a rise in the C-reactive protein of 25% in the absence of an obvious non-infective cause probably indicates sepsis but if there is no change in CRP concentration the diagnosis of sepsis cannot be discounted.
While the evidence suggests that this test is potentially useful in the intensive care unit, it is important to determine its place. To perform this test daily on every patient in the intensive care unit would be extremely expensive and probably not justifiable but it might be useful in patients identified as being at risk of secondary or recurrent sepsis. Even in these, daily testing may be replaced with second or third daily testing to provide a baseline so that change could be detected and measurements could then be performed more frequently when sepsis was suspected.
In conclusion, it is clear that this is not the definitive test for sepsis, but if it is used in conjunction with the more usual markers of infection, both laboratory and clinical, the measurement of changes in plasma concentration of C-reactive protein is a useful adjunct to the diagnosis of sepsis, especially secondary sepsis, in the intensive care unit.
